Gene therapy for haemophilia.
Pasi
K J
KJ
Katharine Dormandy Haemophilia Centre, Department of Haematology, Royal Free Hospital School of Medicine, Hampstead, London, UK.
D000260:Adenoviruses, Human / Q000235:genetics; D000818:Animals; D002130:Calcium Phosphates / Q000494:pharmacology; D002478:Cells, Cultured / Q000637:transplantation; D004274:DNA, Recombinant / Q000008:administration & dosage / Q000235:genetics; D003673:Defective Viruses / Q000235:genetics; D000229:Dependovirus / Q000235:genetics; D004195:Disease Models, Animal; D004285:Dogs; D005164:Factor IX / Q000235:genetics*; D005169:Factor VIII / Q000235:genetics*; D005544:Forecasting; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006467:Hemophilia A / Q000235:genetics / Q000628:therapy*; D002836:Hemophilia B / Q000235:genetics / Q000628:therapy*; D006801:Humans; D051379:Mice; D012190:Retroviridae / Q000235:genetics
D002130:Calcium Phosphates; D004274:DNA, Recombinant; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; D005169:Factor VIII; D005164:Factor IX; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous